QUICK SEARCH

The Quick Search function allows users to search for specific Guidance, Operational advice and Training based on keywords, boolean search and pre-set filters. For more in-depth search, please use the dedicated sections of this platform.

6.2 Medicines used in longer MDR-TB treatment regimens

6.3 Composition of the longer MDR-TB regimens

6.3.1 Choice of components for the longer MDR-TB regimens

6.4 Prolonged use of bedaquiline and concurrent use of bedaquiline and delamanid

6.5 Dosage of the longer MDR-TB regimen components

6.6 Duration of the longer MDR-TB regimens

6.7 Key subgroups

6.8 Treatment monitoring

6.8.1 Monitoring treatment response and outcome assignment

6.8.2 Monitoring safety

7. The bedaquiline, pretomanid and linezolid (BPaL) regimen for MDR-TB with additional fluoroquinolone resistance

7.1 Eligibility

7.2 Composition and duration of the regimen

7.3 Key subgroups

7.4 Considerations for implementation

7.5.1 Monitoring treatment response and outcome assignment

7.5.2 Monitoring safety

7.5.3 Modification or discontinuation of treatment

8.1 Surgery in treatment of M/XDR-TB

8.2 Use of corticosteroids